Error: Could not add to watchlist. X

Hemostemix Inc

+ Watchlist
TIK/P:CN
Ticker Change
TIK/P:CN has changed to a new ticker symbol
CAD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (-) (TTM)
-
Market Cap (CAD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Financials
Industry
Asset Management
Sub-Industry
Investment Companies

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Hemostemix Inc. operates as a biotechnology company that is focused on developing and commercializing blood-derived cell therapies to treat severe medical disorders.
ADDRESS
No 310-16477 64 Avenue
Surrey, BC V3S 6V7
Canada
PHONE
-
  • Elmar R Burchardt
    President/CEO
  • Colleen M Flynn
    Dir:Technical/Secretary
Show More